Betahistine Viatris 16 mg tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Betahistine Dihydrochloride 16 mg

Disponibbli minn:

Viatris GX BV-SRL

Kodiċi ATC:

N07CA01

INN (Isem Internazzjonali):

Betahistine Dihydrochloride

Dożaġġ:

16 mg

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Betahistine Dihydrochloride 16 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Betahistine

Sommarju tal-prodott:

CTI code: 213421-10 - Pack size: 168 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-11 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-01 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-05 - Pack size: 84 - Commercialisation status: YES - FMD code: 05099151910158 - CNK code: 1588631 - Delivery mode: Medical prescription; CTI code: 213421-06 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-07 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-08 - Pack size: 112 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213421-09 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2000-06-05